Readers sound off on diet, winter sports and travel.
The latest news and insights on MS.
Every year, more than 325 MS activists from all over the country gather to celebrate advocacy achievements and kick off the year’s federal policy initiatives at the National MS Society’s Public Policy Conference (PPC). The 2015 conference was held near Washington, D.C., from March 9–11.
The Society’s telelearning series provides information and guidance on current matters essential to living one’s best life with MS. The program offers seven different topics annually. Each free telelearning will feature topic-area expert(s) by phone with online presentations and Q&A session. Presenters are subject to change.
Plegridy (peginterferon beta-1a, manufactured by Biogen Idec) is the newest disease-modifying therapy, or DMT, to be approved by the Food & Drug Administration for relapsing-remitting multiple sclerosis. This makes it the 11th DMT now available to people living with MS.